Plato's Allen says Anthropic has 14 red flags

Plato's David Allen identifies 14 red flags at Anthropic, raising concerns over AI valuations.
David Allen at the Sohn Hearts & Minds Conference Investment Conference in Queenstown.

Alex Gluyas

Plato's Allen says Anthropic has 14 red flags

November 6, 2026
Plato's David Allen identifies 14 red flags at Anthropic, raising concerns over AI valuations.
Read Transcript

Plato Investment Management’s head of long/short strategies David Allen has warned that artificial intelligence giant Anthropic presents 14 red flags and could make an attractive short. 

‍

Allen, who runs Plato’s $6 billion Global Alpha Fund, urged investors to look beyond the hype surrounding Anthropic, warning that the artificial intelligence company’s potential blockbuster initial public offering carries significant financial risks. 

‍

Plato uses a proprietary red flag system to help the hedge fund identify companies to either avoid or short, which is a bet that a share price will fall. On Australian neocloud Firmus, which was forced to pull its IPO, Plato identified 30 so-called red flags. 

‍

Plato has found that eight or more red flags typically resulted in a stock underperforming the benchmark by 20 per cent over the next 12 months. 

‍

Allen acknowledged the Californian startup’s investor appeal, pointing to gross margins of about 85 per cent and “eye-watering” revenue growth. But he said the other side of the balance sheet deserved closer scrutiny. 

‍

His biggest concern is about $US900 billion in largely locked-up commitments, set against revenue streams that are relatively short-term and variable. 

‍

He also questioned the company’s lofty growth expectations, including its claimed $US40 trillion total addressable market – larger than the $US32 trillion US economy. 

‍

Allen flagged concerns about the potential credit quality of its debt, noting BlackRock’s warning that it could be junk-rated, as well as Anthropic’s own disclosures about the potential existential risks posed by its technology. 

‍

“I don’t know if Anthropic is going to be a wonderful success or a terrible investing failure,” he said.

‍

This article was originally posted by Australian Financial Review here.Licensed by Copyright Agency. You must not copy this work without permission.

Plato Investment Management’s head of long/short strategies David Allen has warned that artificial intelligence giant Anthropic presents 14 red flags and could make an attractive short. 

‍

Allen, who runs Plato’s $6 billion Global Alpha Fund, urged investors to look beyond the hype surrounding Anthropic, warning that the artificial intelligence company’s potential blockbuster initial public offering carries significant financial risks. 

‍

Plato uses a proprietary red flag system to help the hedge fund identify companies to either avoid or short, which is a bet that a share price will fall. On Australian neocloud Firmus, which was forced to pull its IPO, Plato identified 30 so-called red flags. 

‍

Plato has found that eight or more red flags typically resulted in a stock underperforming the benchmark by 20 per cent over the next 12 months. 

‍

Allen acknowledged the Californian startup’s investor appeal, pointing to gross margins of about 85 per cent and “eye-watering” revenue growth. But he said the other side of the balance sheet deserved closer scrutiny. 

‍

His biggest concern is about $US900 billion in largely locked-up commitments, set against revenue streams that are relatively short-term and variable. 

‍

He also questioned the company’s lofty growth expectations, including its claimed $US40 trillion total addressable market – larger than the $US32 trillion US economy. 

‍

Allen flagged concerns about the potential credit quality of its debt, noting BlackRock’s warning that it could be junk-rated, as well as Anthropic’s own disclosures about the potential existential risks posed by its technology. 

‍

“I don’t know if Anthropic is going to be a wonderful success or a terrible investing failure,” he said.

‍

This article was originally posted by Australian Financial Review here.Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on November 6, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jeremy Bond presenting at 2023 Sohn Hearts & Minds ConferenceJeremy Bond presenting at 2023 Sohn Hearts & Minds ConferenceJeremy Bond presenting at 2023 Sohn Hearts & Minds ConferenceJeremy Bond presenting at 2023 Sohn Hearts & Minds Conference
September 21, 2026

An Australian fund manager finds redemption in the copper boom

Bond is in hot demand. He’s one of only a handful of speakers invited to return to the Sohn Hearts and Minds charity stockpicking conference, which is being held this year in Queenstown.

Read More
September 23, 2026

‘What is GDP for?’: Strategist Michael Every on the dangers of Australia ignoring economic risks

According to Singapore-based global strategist with Rabobank Michael Every, countries have spent decades optimising for quarterly or annual GDP numbers without asking what growth is actually for: and that is safety, sovereignty and resilience.

Read More
September 23, 2026

He nailed Trump’s big plan. Now he fears Australia’s China-US squeeze

Strategist Michael Every says Trump’s economic statecraft is working, even when it looks messy. But he fears a moment of truth is coming for Australia.

Read More
October 14, 2026

Why US banks are opening new branches, not closing them

US banks are reopening physical branches to attract deposits, strengthen customer relationships and gain market share, showing that face-to-face banking remains valuable despite the shift to digital services.

Read More
October 18, 2026

‘Critically underpriced’

Robert Mullin tips resources surge as AI forces energy market reset

Read More
October 23, 2026

Fundie's stock tips need to pass the dinner party test

John Pinkel backs his conviction in overlooked stocks, from AI chipmaker SK Hynix to sportswear brand ASICS. David Rogers examines the Indus Capital fund manager’s contrarian approach and how he spots opportunities others miss.

Read More
October 24, 2026

Why Samantha D'Amore of Cymer Capital is looking beyond US

Samantha D'Amore shares where she's finding compelling opportunities beyond the US and the global themes shaping her investment approach.

Read More
All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.All Blacks legend Dan Carter (left) with Cooper Cronk at the Sohn Hearts & Minds investment conference in Queenstown.
November 8, 2026

The big lesson for fundies at Sohn came from an All Blacks veteran

At this year’s high-profile stock picking conference, Dan Carter sat down with ex-rugby league star Cooper Cronk and delivered a cut-through message on pressure.

Read More
Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.Isaac Kim of Lightspeed said investors should back AI given the early stage of the technology.
November 6, 2026

Anthropic backer says ‘be long’ on AI as tech rout rips across Asia

Anthropic backer remains bullish on AI despite Asia's tech sell-off.

Read More
Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.Michael Every of Rabobank at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

War on the weekend? Strategist's startling Iran warning

Markets are focused on the AI wreck. But Rabobanks Michael Every says the drums of war haven't stopped beating.

Read More
Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.Ross Cameron at the Sohn Hearts & Minds Conference in Queenstown.
November 6, 2026

Northcape's Ross Cameron pitches Coway

Ross Cameron pitches South Korean home appliance company Coway as a compelling investment opportunity.

Read More
December 19, 2024

Rikki Bannan – Don’t get caught up in momentum

Conference Fund Manager Rikki Bannan, Executive Director at IFM Investors, joins Equity Mates to discuss her standout 2023 stock pick, Telix, and explore what opportunities lie ahead.

Read More
November 20, 2024

Trump unifies top investors in decade-long bullish outlook for US

Nick Moakes, CIO of the $72 billion Wellcome Trust, told the conference that too many investors were banking on a return to the ultra-low interest rates that prevailed over the past decade.

Read More
Wall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben SearcyWall Street legend Howard Marks told the Sohn event that US exceptionalism would endure. Picture: Ben Searcy
November 17, 2024

Is anyone brave or stupid enough to bet against America?

Stock pickers have been punished for betting against the US. The choice between consensus and contrarianism on American exceptionalism is now harder than ever.

Read More
Ellerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy PhotographyEllerston Capital's Chris Kourtis says things will improve at embattled fund manager Perpetual. Picture: Ben Searcy Photography
November 15, 2024

Eleven stock tips from Sohn to get you through 2025

“There’s no finer place for the finance festival than in the festival city,” said Matthew Grounds. He, along with fellow Barrenjoey co-executive chairman Guy Fowler and investor Gary Weiss, is one of Sohn’s driving forces.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.